Evotec Evotec, Takeda Pharmaceuticals Partner on RNA-Targeting Drug Development The companies will work together to identify and develop small molecule drugs against RNA targets that fit within Takeda's disease areas of focus. Evotec, Indivumed to Collaborate on Non-Small Cell Lung Cancer Drug Discovery The deal comes on the heels of a colorectal cancer-focused drug-discovery alliance that the German companies formed in early 2019. Evotec, Celmatix Partner on Women's Reproductive Health Drug Discovery About a year ago, New York City-based Celmatix launched a division to discover therapeutics for women's health indications including reproductive disorders. Evotec Acquires iPSC Drug-Discovery Assets From Ncardia The assets include intellectual property relevant to iPSC-based phenotypic drug discovery and an existing product business around iPSC-derived cells. Evotec, Indivumed Partner on Colorectal Cancer Drug Discovery Evotec will access Indivumed's IndivuType multi-omics cancer database to discover and develop new precision therapeutics for colorectal cancer. Sep 6, 2018 Evotec, Celgene Partner on Targeted Protein Degradation for Drug Discovery Aug 27, 2018 Centogene, Evotec Forge Drug-Discovery Alliance May 2, 2018 Evotec Licenses CRISPR-Cas9 Technology From ERS Dec 4, 2017 Ncardia, Evotec Sign Licencing Agreement for iPS Cell Disease Modeling Aug 4, 2017 In Brief This Week: Thermo Fisher, Grifols, MDxHealth, Exosome Diagnostics, and More Nov 30, 2016 Evotec Inks Deal to Offer Merck KGaA Gene Editing, Silencing Technologies Jul 6, 2016 Evotec Licenses CRISPR Tech From Broad Institute, Harvard Sep 11, 2014 CHDI Extends Evotec Huntington's Collaboration Through 2017 Apr 25, 2014 Evotec-Roche Deal Indicates Adoption of Mass Spec, Hi-Res Instrumentation for Clinical Protein Quant Premium Sep 12, 2013 Evotec, HSCI Ink ALS Deal Sep 6, 2013 String of Recent Deals Suggests Ag-Bio Market an Opportunity for Chemical Proteomics Firms Premium Aug 21, 2013 Evotec, Jain Foundation Expand Muscular Dystrophy Collaboration Jul 9, 2013 Evotec, Dow AgroSciences Enter Proteomics Service Deal Jan 4, 2013 Evotec Inks Deal with Apeiron to Use Chemical Proteomics in Cancer Drug Development Premium Jan 3, 2013 Evotec Buys Cell-based Reagents Firm for up to $2.9M Sep 21, 2012 In Brief This Week: Roche; Life Technologies; Trovagene, Strand; Fluidigm; Wellington Partners; Proteros, UCB; Evotec May 18, 2012 GSK to Buy Cellzome for $99M as Pharma Interest in Chemical Proteomics Continues to Build Premium Apr 20, 2012 UNC Team Takes Proteomic Approach to Study Drug Resistance in Triple-Negative Breast Cancer Premium Jul 1, 2011 Evotec to Use PhosphoScout Platform in Oncology Biomarker Alliance with Roche Premium Jun 24, 2011 Roche, Evotec Partner on Protein Biomarkers for Cancer Drugs Load More Breaking News Pediatric Medulloblastoma Subgroups May Benefit from Lower-Dose Radiation Therapy Space Radiation Shows Limited Effects on Mammalian Sperm DNA, Fertility Bluestar Genomics Sues Former Consultant, Ludwig Institute for Cancer Research Over IP Ownership New Products Posted to GenomeWeb: 10x Genomics, Swift Biosciences, Agilent Technologies, More In Brief This Week: Quantum-Si, TGen, Yale, and More People in the News: New Appointments at Invitae, PGDx, Oxford Nanopore, PacBio, More The Scan Fertility Fraud Found Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today. Ties Between Vigorous Exercise, ALS in Genetically At-Risk People Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports. Test Warning The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK. Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.